Skip to content
2000
  1. Home
  2. A-Z Publications
  3. New Emirates Medical Journal
  4. Fast Track Articles
  5. Fast Track Article
image of Exploring the Intricacies of Polycystic Ovarian Syndrome (PCOS): A Comprehensive Review-from Prevalence to Natural Solutions
file format pdf download PDF

Abstract

Introduction:

Among women of reproductive age, Polycystic Ovarian Syndrome (PCOS) is a common endocrine condition marked by insulin resistance, metabolic abnormalities, and hormonal imbalances. Infertility, irregular menstrual periods, acne, hirsutism, and obesity are among the symptoms that this illness frequently causes. Traditional PCOS therapies usually include drugs like insulin sensitizers and oral contraceptives, which can have negative side effects and might not deal with the underlying causes of the condition. This study aims to examine the etiology of PCOS and the effectiveness of natural management techniques in reducing symptoms and enhancing general health outcomes.

Aims and Objective:

The objective of this study is to comprehend the pathophysiology and underlying mechanisms of PCOS, including hormonal and metabolic factors, assess the effectiveness of natural management strategies, such as dietary changes, herbal supplements, physical activity, and lifestyle interventions, in managing symptoms, investigate the effects of particular diets and lifestyle changes on insulin sensitivity, inflammation, and hormonal balance in PCOS patients, compare natural strategies with conventional treatments to determine the advantages and disadvantages of each treatment, identify research gaps, and suggest areas for future study.

Methodology:

A thorough examination of pertinent literature, including clinical studies, randomized controlled trials, and meta-analyses published in peer-reviewed journals, was a part of the search approach. Studies on the pathophysiology of PCOS, traditional therapies, and natural management strategies were found using databases like PubMed, Scopus, and Web of Science.

Results:

The review concentrated on studies conducted within the last 15 years to guarantee that the most recent findings were included. This study intends to shed light on the possible advantages of incorporating natural methods into PCOS care by combining the available data and comprehensive treatment choices.

Conclusion:

In summary, PCOS is a common and complex disorder that affects women's health worldwide. Effective management requires knowledge of its symptoms, risk factors, and underlying mechanisms. Women can be empowered to manage PCOS better and enhance their general well-being by emphasizing a holistic approach that incorporates lifestyle changes and natural therapies.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/nemj/10.2174/0102506882339236250105165820
2025-01-09
2025-01-19

  • From This Site

    /content/journals/nemj/10.2174/0102506882339236250105165820
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/nemj/10.2174/0102506882339236250105165820/e02506882339236.html?itemId=/content/journals/nemj/10.2174/0102506882339236250105165820&mimeType=html&fmt=ahah

References

  1. Azziz R. Carmina E. Dewailly D. Kandarakis D.E. Morreale E.H.F. Futterweit W. Janssen O.E. Legro R.S. Norman R.J. Taylor A.E. Witchel S.F. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: The complete task force report. Fertil. Steril. 2009 91 2 456 488 10.1016/j.fertnstert.2008.06.035 18950759
    [Google Scholar]
  2. Asmabi M.A. Jithesh M.K. Ayurveda management of infertility associated with poly cystic ovarian syndrome: A case report. J. Ayurveda Integr. Med. 2022 13 2 100513 10.1016/j.jaim.2021.08.006 34980524
    [Google Scholar]
  3. Lashen H. Review: Role of metformin in the management of polycystic ovary syndrome. Ther. Adv. Endocrinol. Metab. 2010 1 3 117 128 10.1177/2042018810380215 23148156
    [Google Scholar]
  4. Kafali H. Iriadam M. Ozardalı I. Demir N. Letrozole-induced polycystic ovaries in the rat: A new model for cystic ovarian disease. Arch. Med. Res. 2004 35 2 103 108 10.1016/j.arcmed.2003.10.005 15010188
    [Google Scholar]
  5. Pundir C.S. Deswal R. Narwal V. Dang A. The prevalence of polycystic ovary syndrome: A brief systematic review. J. Hum. Reprod. Sci. 2020 13 4 261 271 10.4103/jhrs.JHRS_95_18 33627974
    [Google Scholar]
  6. Bharathi V.R. Swetha S. Neerajaa J. Madhavica V.J. Janani D.M. Rekha S.N. S R. B U. An epidemiological survey: Effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil. Soc. J. 2017 22 4 313 316 10.1016/j.mefs.2017.05.007
    [Google Scholar]
  7. Allahbadia G.N. Merchant R. Polycystic ovary syndrome and impact on health. Middle East Fertil. Soc. J. 2011 16 1 19 37 10.1016/j.mefs.2010.10.002
    [Google Scholar]
  8. Pasquali R. Victorin S.E. Yildiz B.O. Duleba A.J. Hoeger K. Mason H. Homburg R. Hickey T. Franks S. Tapanainen J.S. Balen A. Abbott D.H. Kandarakis D.E. Legro R.S. PCOS Forum: Research in polycystic ovary syndrome today and tomorrow. Clin. Endocrinol. 2011 74 4 424 433 10.1111/j.1365‑2265.2010.03956.x 21158892
    [Google Scholar]
  9. Scicchitano P. Dentamaro I. Carbonara R. Bulzis G. Dachille A. Caputo P. Riccardi R. Locorotondo M. Mandurino C. Ciccone M. Cardiovascular risk in women with PCOS. Int. J. Endocrinol. Metab. 2012 10 4 611 618 10.5812/ijem.4020 23843832
    [Google Scholar]
  10. Amini L. Tehranian N. Movahedin M. Tehrani R.F. Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: A systematic review of clinical trials. Iran. J. Reprod. Med. 2015 13 1 1 8 25653669
    [Google Scholar]
  11. Sedighi S. Akbari A.A.S. Afrakhteh M. Esteki T. Majd A.H. Mahmoodi Z. Comparison of lifestyle in women with polycystic ovary syndrome and healthy women. Glob. J. Health Sci. 2014 7 1 228 234 10.5539/gjhs.v7n1p228 25560358
    [Google Scholar]
  12. Siriwardene D.S.A. Karunathilaka L.P.A. Kodituwakku N.D. Karunarathne Y.A.U.D. Clinical efficacy of Ayurveda treatment regimen on Subfertility with poly cystic ovarian syndrome (PCOS). Ayu 2010 31 1 24 27 10.4103/0974‑8520.68203 22131680
    [Google Scholar]
  13. Goswami P.K. Khale A. Ogale S. Natural remedies for polycystic ovarian syndrome (PCOS): A review. Int J Pharm Phytopharmacol Res. 2012 1 6 396 402
    [Google Scholar]
  14. Zhao X. Ni R. Li L. Mo Y. Huang J. Huang M. Azziz R. Yang D. Defining hirsutism in Chinese women: A cross-sectional study. Fertil. Steril. 2011 96 3 792 796 10.1016/j.fertnstert.2011.06.040 21762890
    [Google Scholar]
  15. Qaid M.M. Abdelrahman M.M. Role of insulin and other related hormones in energy metabolism—A review. Cogent Food Agric. 2016 2 1 1267691 10.1080/23311932.2016.1267691
    [Google Scholar]
  16. Nidhi R. Padmalatha V. Nagarathna R. Ram A. Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 2012 118 1 37 41 10.1016/j.ijgo.2012.01.027 22507264
    [Google Scholar]
  17. Unluhizarci K. Karaca Z. Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World J. Diabetes 2021 12 5 616 629 10.4239/wjd.v12.i5.616 33995849
    [Google Scholar]
  18. Cussen L. McDonnell T. Bennett G. Thompson C.J. Sherlock M. O’Reilly M.W. Approach to androgen excess in women: Clinical and biochemical insights. Clin. Endocrinol. 2022 97 2 174 186 10.1111/cen.14710 35349173
    [Google Scholar]
  19. Kwon C.Y. Cho I.H. Park K.S. Therapeutic effects and mechanisms of herbal medicines for treating polycystic ovary syndrome: A review. Front. Pharmacol. 2020 11 1192 10.3389/fphar.2020.01192 32903374
    [Google Scholar]
  20. Cappelli V. Musacchio M.C. Bulfoni A. Morgante G. Leo D.V. Natural molecules for the therapy of hyperandrogenism and metabolic disorders in PCOS. Eur. Rev. Med. Pharmacol. Sci. 2017 21 2 15 29 28724177
    [Google Scholar]
  21. Kwon C.Y. Lee B. Park K.S. Oriental herbal medicine and moxibustion for polycystic ovary syndrome. Medicine 2018 97 43 e12942 10.1097/MD.0000000000012942 30412108
    [Google Scholar]
  22. Balen A. The pathophysiology of polycystic ovary syndrome: Trying to understand PCOS and its endocrinology. Best Pract. Res. Clin. Obstet. Gynaecol. 2004 18 5 685 706 10.1016/j.bpobgyn.2004.05.004 15380141
    [Google Scholar]
  23. Kumarapeli V. Seneviratne R.A. Wijeyaratne C.N. Yapa R.M.S.C. Dodampahala S.H. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am. J. Epidemiol. 2008 168 3 321 328 10.1093/aje/kwn137 18550559
    [Google Scholar]
  24. Nautiyal H. Imam S.S. Alshehri S. Ghoneim M.M. Afzal M. Alzarea S.I. Güven E. Abbasi A.F.A. Kazmi I. Polycystic ovarian syndrome: A complex disease with a genetics approach. Biomedicines 2022 10 3 540 10.3390/biomedicines10030540 35327342
    [Google Scholar]
  25. Garg D. Tal R. The role of AMH in the pathophysiology of polycystic ovarian syndrome. Reprod. Biomed. Online 2016 33 1 15 28 10.1016/j.rbmo.2016.04.007 27174394
    [Google Scholar]
  26. Begum GS Shariff A Ayman G Mohammad B Housam R Khaled N Assessment of risk factors for development of polycystic ovarian syndrome. Diabetes 2017 4 1 164 167
    [Google Scholar]
  27. Pelluri R. Srikanth K. Paritala H. Ravi V. Kamma M.S.P. Piduguralla K.D. Venkateswarlu U. Subrahmanyam J. Bannaravuri K. Thunga T. Vemparala R. Doddapaneni S. Avulamanda N. Sivani V. Puttagunta S. The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients. Clin. Epidemiol. Glob. Health 2021 12 100910 10.1016/j.cegh.2021.100910
    [Google Scholar]
  28. O’Reilly M. Gathercole L. Capper F. Arlt W. Tomlinson J. Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome. Lancet 2015 385 S16 10.1016/S0140‑6736(15)60331‑2 26312838
    [Google Scholar]
  29. Malik S. Saeed S. Saleem A. Khan M.I. Khan A. Akhtar M.F. Alternative treatment of polycystic ovary syndrome: Pre-clinical and clinical basis for using plant-based drugs. Front. Endocrinol. 2024 14 1294406 10.3389/fendo.2023.1294406 38725974
    [Google Scholar]
  30. Arentz S. Abbott J.A. Smith C.A. Bensoussan A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; A review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement. Altern. Med. 2014 14 1 511 10.1186/1472‑6882‑14‑511 25524718
    [Google Scholar]
  31. Norman R.J. Dewailly D. Legro R.S. Hickey T.E. Polycystic ovary syndrome. Lancet 2007 370 9588 685 697 10.1016/S0140‑6736(07)61345‑2 17720020
    [Google Scholar]
  32. Khanage S.G. Subhash T.Y. Bhaiyyasaheb I.R. Herbal drugs for the treatment of polycystic ovary syndrome (PCOS) and its complications. Pharm. Res. 2019 2 1 5 13 31823112
    [Google Scholar]
  33. Dunne N. The natural diet solution for PCOS and Infertility: How to manage polycystic ovary syndrome naturally. Natural Solutions for PCOS 2006
    [Google Scholar]
  34. Legro R.S. Barnhart H.X. Schlaff W.D. Carr B.R. Diamond M.P. Carson S.A. Steinkampf M.P. Coutifaris C. McGovern P.G. Cataldo N.A. Gosman G.G. Nestler J.E. Giudice L.C. Leppert P.C. Myers E.R. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 2007 356 6 551 566 10.1056/NEJMoa063971 17287476
    [Google Scholar]
  35. Armanini D. Castello R. Scaroni C. Bonanni G. Faccini G. Pellati D. Bertoldo A. Fiore C. Moghetti P. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur. J. Obstet. Gynecol. Reprod. Biol. 2007 131 1 61 67 10.1016/j.ejogrb.2006.10.013 17113210
    [Google Scholar]
  36. Felemban A. Tan S.L. Tulandi T. Laparoscopic treatment of polycystic ovaries with insulated needle cautery: A reappraisal. Fertil. Steril. 2000 73 2 266 269 10.1016/S0015‑0282(99)00534‑8 10685526
    [Google Scholar]
  37. Abasian Z. Rostamzadeh A. Mohammadi M. Hosseini M. kopaei R.M. A review on role of medicinal plants in polycystic ovarian syndrome: Pathophysiology, neuroendocrine signaling, therapeutic status and future prospects. Middle East Fertil. Soc. J. 2018 23 4 255 262 10.1016/j.mefs.2018.04.005
    [Google Scholar]
  38. Tilburt J.C. Kaptchuk T.J. Herbal medicine research and global health: An ethical analysis. Bullet. World Health Org. 2008 86 8 594 599 10.2471/BLT.07.042820
    [Google Scholar]
  39. Ganie M. Vasudevan V. Wani I. Baba M. Arif T. Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J. Med. Res. 2019 150 4 333 344 10.4103/ijmr.IJMR_1937_17 31823915
    [Google Scholar]
  40. Stankiewicz M. Norman R. Diagnosis and management of polycystic ovary syndrome: A practical guide. Drugs 2006 66 7 903 912 10.2165/00003495‑200666070‑00002 16740005
    [Google Scholar]
  41. Kandarakis D.E. Baillargeon J.P. Iuorno M.J. Jakubowicz D.J. Nestler J.E. A modern medical quandary: Polycystic ovary syndrome, insulin resistance, and oral contraceptive pills. J. Clin. Endocrinol. Metab. 2003 88 5 1927 1932 10.1210/jc.2002‑021528 12727935
    [Google Scholar]
  42. Halikias I. Lytras A. Syriou V. Tolis G. Combined oral contraceptives and gonadotropin releasing hormone agonistic analogs in polycystic ovary syndrome: Clinical and experimental studies. Eur. J. Contracept. Reprod. Health Care 1997 2 4 213 224 10.3109/13625189709165297 9678076
    [Google Scholar]
  43. Barbieri R.L. Metformin for the treatment of polycystic ovary syndrome. Obstet. Gynecol. 2003 101 4 785 793 10.1016/S0029‑7844(03)00045‑0 12681887
    [Google Scholar]
  44. Christy N.A. Franks A.S. Cross L.B. Spironolactone for hirsutism in polycystic ovary syndrome. Ann. Pharmacother. 2005 39 9 1517 1521 10.1345/aph.1G025 16076921
    [Google Scholar]
  45. Rodin D.A. Bano G. Bland J.M. Taylor K. Nussey S.S. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women. Clin. Endocrinol. 1998 49 1 91 99 10.1046/j.1365‑2265.1998.00492.x 9797852
    [Google Scholar]
  46. Ong M. Peng J. Jin X. Qu X. Chinese herbal medicine for the optimal management of polycystic ovary syndrome. Am. J. Chin. Med. 2017 45 3 405 422 10.1142/S0192415X17500252 28359195
    [Google Scholar]
  47. Kamble AV Dhamane SP Kulkarni AS Potnis VV Review on effects of herbal extract for the treatment of polycystic ovarian syndrome (PCOS). Plant Arch. 2020 20 1 1189 1195
    [Google Scholar]
  48. Gade R. Dwarampudi L.P. Dharshini S.P. Raj R.K. Polycystic ovarian syndrome (PCOS): Approach to traditional systems, natural and bio-chemical compounds for its management. Indian J. Biochem. Biophys. 2022 59 5 521 527
    [Google Scholar]
  49. Jungbauer A. Medjakovic S. Phytoestrogens and the metabolic syndrome. J. Steroid Biochem. Mol. Biol. 2014 139 277 289 10.1016/j.jsbmb.2012.12.009 23318879
    [Google Scholar]
  50. Manouchehri A. Abbaszadeh S. Ahmadi M. Nejad F.K. Bahmani M. Dastyar N. Polycystic ovaries and herbal remedies: A systematic review. JBRA Assist. Reprod. 2023 27 1 85 91 35916457
    [Google Scholar]
  51. Sasikala S.L. Shamila S. A novel Ayurvedic medicine-Asokarishtam in the treatment of LETROZOLE induced PCOS in rat. J. Cell Tissue Res. 2009 9 2 1903
    [Google Scholar]
  52. Jazani M.A. Azgomi D.N.H. Azgomi D.N.A. Azgomi D.N.R. A comprehensive review of clinical studies with herbal medicine on polycystic ovary syndrome (PCOS). Daru 2019 27 2 863 877 10.1007/s40199‑019‑00312‑0 31741280
    [Google Scholar]
  53. Kumarapeli M. Karunagoda K.P. Perera P.K. A randomized clinical trial to evaluate the efficacy of Satapushpashatavari powered drug with Satapushpa-shatavari grita for the management of polycystic ovary syndrome (PCOS). IJPSR 2018 9 6 2494 2499
    [Google Scholar]
  54. Mokaberinejad R. Rampisheh Z. Aliasl J. Akhtari E. The comparison of fennel infusion plus dry cupping versus metformin in management of oligomenorrhoea in patients with polycystic ovary syndrome: A randomised clinical trial. J. Obstet. Gynaecol. 2019 39 5 652 658 10.1080/01443615.2018.1541232 30856025
    [Google Scholar]
  55. Borzoei A. Rafraf M. Niromanesh S. Farzadi L. Narimani F. Doostan F. Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome. J. Tradit. Complement. Med. 2018 8 1 128 133 10.1016/j.jtcme.2017.04.008 29322000
    [Google Scholar]
  56. Allahdadian M. Tehrani H.G. Zarre F. Ranjbar H. Allahdadian F. Effect of green tea on metabolic and hormonal aspect of polycystic ovarian syndrome in overweight and obese women suffering from polycystic ovarian syndrome: A clinical trial. J. Educ. Health Promot. 2017 6 1 36 10.4103/jehp.jehp_67_15 28584836
    [Google Scholar]
  57. Swaroop A. Jaipuriar A.S. Gupta S.K. Bagchi M. Kumar P. Preuss H.G. Bagchi D. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, FurocystTM) in polycystic ovary syndrome (PCOS). Int. J. Med. Sci. 2015 12 10 825 831 10.7150/ijms.13024 26516311
    [Google Scholar]
  58. Dou L. Zheng Y. Li L. Gui X. Chen Y. Yu M. Guo Y. The effect of cinnamon on polycystic ovary syndrome in a mouse model. Reprod. Biol. Endocrinol. 2018 16 1 99 10.1186/s12958‑018‑0418‑y 30340496
    [Google Scholar]
  59. Grant P. Spearmint herbal tea has significant anti‐androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother. Res. 2010 24 2 186 188 10.1002/ptr.2900 19585478
    [Google Scholar]
  60. Mamaghani E.M. Asl S.M. Pirouzpanah S. Jafarabadi A.M. Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome: A randomized controlled clinical trial. J. Obstet. Gynaecol. Res. 2014 40 4 1067 1076 10.1111/jog.12311 24612081
    [Google Scholar]
  61. Naeimi SA Hajimehdipoor H Saber S Comparing the effect of Nigella sativa oil soft gel and placebo on oligomenorrhea, amenorrhea and laboratory characteristics in patients with polycystic ovarian syndrome, a randomized clinical trial. Res. J. Pharm. 2020 7 1 49 59
    [Google Scholar]
  62. Fan C.W. Hutcherson C.N.E. Hutcherson T.C. Systematic review of black cohosh (Cimicifuga racemosa) for management of polycystic ovary syndrome-related infertility. J. Pharm. Pract. 2022 35 6 991 999 10.1177/08971900211012244 33926292
    [Google Scholar]
  63. Azouz A.A. Ali S.E. Elsalam A.R.M. Emam S.R. Galal M.K. Elmosalamy S.H. Alsherbiny M.A. Hassan B.B. Li C.G. Badawy E.S.A. Modulation of steroidogenesis by Actaea racemosa and vitamin C combination, in letrozole induced polycystic ovarian syndrome rat model: Promising activity without the risk of hepatic adverse effect. Chin. Med. 2021 16 1 36 10.1186/s13020‑021‑00444‑z 33926485
    [Google Scholar]
  64. Zeng L.H. Rana S. Hussain L. Asif M. Mehmood M.H. Imran I. Younas A. Mahdy A. Joufi A.F.A. Abed S.N. Polycystic ovary syndrome: A disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. Front. Pharmacol. 2022 13 874914 10.3389/fphar.2022.874914 35924049
    [Google Scholar]
  65. Soumya V. Muzib Y.I. Venkatesh P. A novel method of extraction of bamboo seed oil (Bambusa bambos Druce) and its promising effect on metabolic symptoms of experimentally induced polycystic ovarian disease. Indian J. Pharmacol. 2016 48 2 162 167 10.4103/0253‑7613.178833 27127318
    [Google Scholar]
  66. Nampoothiri L.P. Desai B.N. Maharjan R.H. Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model. Pharmacognosy Res. 2012 4 2 109 115 10.4103/0974‑8490.94736 22518083
    [Google Scholar]
  67. Nampoothiri L. Maharjan R. Nagar P.S. Effect of Aloe barbadensis Mill. Formulation on Letrozole induced polycystic ovarian syndrome rat model. J. Ayurveda Integr. Med. 2010 1 4 273 279 10.4103/0975‑9476.74090 21731374
    [Google Scholar]
  68. Shanbhag T. Shrestha J. Shenoy S. Amuthan A. Prabhu K. Sharma S. Banerjee S. Kafle S. Antiovulatory and abortifacient effects of Areca catechu (betel nut) in female rats. Indian J. Pharmacol. 2010 42 5 306 311 10.4103/0253‑7613.70350 21206624
    [Google Scholar]
  69. Dhanalakshmi S. Dhivya C. A perspective studies on herbalism for the preventive of PCOS. Res. J. Pharm. Technol. 2018 11 12 5417 5424 10.5958/0974‑360X.2018.00989.7
    [Google Scholar]
  70. Lim S.S. Hutchison S.K. Ryswyk V.E. Norman R.J. Teede H.J. Moran L.J. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Libr. 2019 2019 3 CD007506 10.1002/14651858.CD007506.pub4 30921477
    [Google Scholar]
  71. Rathee P. Rathee S. A review of polycystic ovarian syndrome in ayurveda. Int. Res. J. Ayurveda Yoga 2022 5 2 114 117 10.47223/IRJAY.2022.5220
    [Google Scholar]
  72. Soni Morphology, phytochemistry and pharmacological potential of Asparagus racemosus. World J. Pharm. Res. Technol. 2022 11 3 101 117
    [Google Scholar]
  73. Farkhad A.S. Khazali H. Therapeutic effects of isoflavone-aglycone fraction from soybean ( Glycine max L. Merrill) in rats with estradiol valerate-induced polycystic ovary syndrome as an inflammatory state. Gynecol. Endocrinol. 2019 35 12 1078 1083 10.1080/09513590.2019.1624715 31185755
    [Google Scholar]
  74. Zhou J. Barry J.A. Pan J.X. Wang F.F. Fu Z.Z. Hardiman P.J. Duez P. Qu F. An atractylodes macrocephala koidz extract alleviates hyperandrogenism of polycystic ovarian syndrome. Int. J. Clin. Exp. Med. 2016 9 2 2758 2767
    [Google Scholar]
  75. Sankhwar P. Jaiswar S.P. Yadav S. Awasthi V. Goel A. Kumar P. Banik S.P. Bagchi M. Bagchi D. Beneficial effects of a novel fenugreek seed extract (Trigonella foenum-graecum, furocyst) in women with polycystic ovary syndrome (PCOS): A follow-up compliance clinical investigation. J. Am. Nutr. Assoc. 2023 42 7 691 699 10.1080/27697061.2022.2145526 36441141
    [Google Scholar]
  76. Harada M. Pathophysiology of polycystic ovary syndrome revisited: Current understanding and perspectives regarding future research. Reprod. Med. Biol. 2022 21 1 e12487 10.1002/rmb2.12487 36310656
    [Google Scholar]
  77. Zanzibar Traditional and Alternative Medicine Policy Ministry of Health and Social Welfare in Collaboration with. World Health Organization 2008
    [Google Scholar]
  78. Ghafurniyan H. Azarnia M. Nabiuni M. Karimzadeh L. The effect of green tea extract on reproductive improvement in estradiol valerate-induced polycystic ovarian syndrome in rat. Iran. J. Pharm. Res. 2015 14 4 1215 1233 26664389
    [Google Scholar]
  79. Alaee S. Bagheri M.J. Ataabadi M.S. Koohpeyma F. Capacity of Mentha spicata (spearmint) extracts in alleviating hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome rat model. World’s. Vet. J. 2020 3 451 456
    [Google Scholar]
  80. Elsheikh M. Murphy C. Polycystic ovary syndrome. Oxford University Press 2008 10.1093/oso/9780199213689.001.0001
    [Google Scholar]
  81. Farideh Z.Z. Bagher M. Ashraf A. Akram A. Kazem M. Effects of chamomile extract on biochemical and clinical parameters in a rat model of polycystic ovary syndrome. J. Reprod. Infertil. 2010 11 3 169 174 23926485
    [Google Scholar]
  82. Novakovic S. Jakovljevic V. Jovic N. Andric K. Milinkovic M. Anicic T. Pindovic B. Kareva E.N. Fisenko V.P. Dimitrijevic A. Jovic J.J. Exploring the antioxidative effects of ginger and cinnamon: A comprehensive review of evidence and molecular mechanisms involved in polycystic ovary syndrome (PCOS) and other oxidative stress-related disorders. Antioxidants 2024 13 4 392 10.3390/antiox13040392 38671840
    [Google Scholar]
  83. Wal A Wal P Saraswat N Wadhwa S. A detailed review on herbal treatments for treatment of PCOS-polycystic ovary syndrome (PCOS). Curr. Nut. 2021 2 2174 2665978602666210805092103 10.2174/2665978602666210805092103
    [Google Scholar]
  84. Alwan S.H. Saeed A.M.H. Biosynthesized silver nanoparticles (using Cinnamomum zeylanicum bark extract) improve the fertility status of rats with polycystic ovarian syndrome. Biocatal. Agric. Biotechnol. 2021 38 102217 10.1016/j.bcab.2021.102217
    [Google Scholar]
  85. Soumya V. Muzib Y.I. Venkatesh P. Hariprasath K. GC-MS analysis of Cocus nucifera flower extract and its effects on heterogeneous symptoms of polycystic ovarian disease in female Wistar rats. Chin. J. Nat. Med. 2014 12 9 677 684 10.1016/S1875‑5364(14)60103‑5 25263979
    [Google Scholar]
  86. Lima E.B.C. Sousa C.N.S. Meneses L.N. Ximenes N.C. Júnior S.M.A. Vasconcelos G.S. Lima N.B.C. Patrocínio M.C.A. Macedo D. Vasconcelos S.M.M. Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review. Braz. J. Med. Biol. Res. 2015 48 11 953 964 10.1590/1414‑431x20154773 26292222
    [Google Scholar]
  87. Azin F. Khazali H. Phytotherapy of polycystic ovary syndrome: A review. Int. J. Reprod. Biomed. 2022 20 1 13 20 10.18502/ijrm.v20i1.10404 35308325
    [Google Scholar]
  88. Shoaibinobarian N. Eslamian G. Noormohammadi M. Malek S. Rouhani S. Mirmohammadali S.N. Dietary total antioxidant capacity and risk of polycystic ovary syndrome: A case-control study. Int. J. Fertil. Steril. 2022 16 3 200 205 10.22074/ijfs.2021.526579.1107 36029057
    [Google Scholar]
  89. Kooti W. Moradi M. Akbari A.S. Ahvazi S.N. Samani A.M. Larky A.D. Therapeutic and pharmacological potential of Foeniculum vulgare Mill: A review. J. HerbMed Pharm. 2015 4 1 1 9
    [Google Scholar]
  90. Mahboubi M. Foeniculum vulgare as valuable plant in management of women’s health. J. Menopausal Med. 2019 25 1 1 14 10.6118/jmm.2019.25.1.1 31080784
    [Google Scholar]
  91. Sadrefozalayi S. Farokhi F. Effect of the aqueous extract of Foeniculum vulgare (fennel) on the kidney in experimental PCOS female rats. Avicenna J. Phytomed. 2014 4 2 110 117 25050308
    [Google Scholar]
  92. Khosrowpour Z. Fahimi S. Faizi M. Shaaban Z. Tansaz M. Sahranavard S. Evaluation of formulated herbal syrup (Containing Fennel, Anise, and Celery) on the letrozole-induced polycystic ovary syndrome model. Jundishapur J. Nat. Pharm. Prod. 2022 17 2 e120814 10.5812/jjnpp‑120814
    [Google Scholar]
  93. Eivari A.S.H. Moghimian M. Soltani M. Shoorei H. Asghari R. Hajizadeh H. Shokoohi M. Alami S. Ghaderi K.F. The effect of Galega officinalis on hormonal and metabolic profile in a rat model of polycystic ovary syndrome. Int. J. Women’s Health Reprod. Sci. 2017 6 3 276 282 10.15296/ijwhr.2018.46
    [Google Scholar]
  94. Esmaeilinezhad Z. Babajafari S. Sohrabi Z. Eskandari M.H. Amooee S. Boldaji B.R. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutr. Metab. Cardiovasc. Dis. 2019 29 2 201 208 10.1016/j.numecd.2018.07.002 30538082
    [Google Scholar]
  95. Rajan R.K. M S.S.K. Balaji B. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Pharm. Biol. 2017 55 1 242 251 10.1080/13880209.2016.1258425 27927075
    [Google Scholar]
  96. Armanini D. Mattarello M.J. Fiore C. Bonanni G. Scaroni C. Sartorato P. Palermo M. Licorice reduces serum testosterone in healthy women. Steroids 2004 69 11-12 763 766 10.1016/j.steroids.2004.09.005 15579328
    [Google Scholar]
  97. Yang H. Kim H.J. Pyun B.J. Lee H.W. Licorice ethanol extract improves symptoms of polycytic ovary syndrome in Letrozole-induced female rats. Integr. Med. Res. 2018 7 3 264 270 10.1016/j.imr.2018.05.003 30271715
    [Google Scholar]
  98. Shuid A.N. Ping L.L. Muhammad N. Mohamed N. Soelaiman I.N. The effects of Labisia pumila var. alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis. J. Ethnopharmacol. 2011 133 2 538 542 10.1016/j.jep.2010.10.033 20971181
    [Google Scholar]
  99. Napoli D.A. Zucchetti P. A comprehensive review of the benefits of Taraxacum officinale on human health. Bull. Natl. Res. Cent. 2021 45 1 110 10.1186/s42269‑021‑00567‑1
    [Google Scholar]
  100. Mannerås L. Fazliana M. Nazaimoon W.W.M. Lönn M. Gu H.F. Östenson C.G. Victorin S.E. Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome. J. Ethnopharmacol. 2010 127 2 346 351 10.1016/j.jep.2009.10.032 19883744
    [Google Scholar]
  101. Gonzales G.F. Córdova A. Vega K. Chung A. Villena A. Góñez C. Effect of Lepidium meyenii (Maca), a root with aphrodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. J. Endocrinol. 2003 176 1 163 168 10.1677/joe.0.1760163 12525260
    [Google Scholar]
  102. Meissner H. Bilinska R.H. Mscisz A. Kedzia B. Therapeutic effects of pre-gelatinized maca (Lepidium peruvianum Chacon) used as a non-hormonal alternative to hrt in perimenopausal women - clinical pilot study. Int. J. Biomed. Sci. 2006 2 2 143 159 10.59566/IJBS.2006.2143 23674976
    [Google Scholar]
  103. Yaquetto D.E. Aparicio V.M. Gonzales G.F. The antioxidant effect of Peruvian maca (Lepidium meyenii). InToxicology. Academic Press 2021 519 525 10.1016/B978‑0‑12‑819092‑0.00050‑9
    [Google Scholar]
  104. Romm A. Botanical medicine for women’s health E-book: Botanical medicine for women’s health E-book. Elsevier Health Sciences 2017
    [Google Scholar]
  105. Mokhtari M. Ebrahimpoor M.R. Harfsheno S. The effects of alcoholic extract of Marrubum vulgare on hormonal parameters in female rat model of polycystic ovarian syndrome. Med. Sci. J. Islam. Azad Uni. Tehran Med. Branch 2014 24 2 74 80
    [Google Scholar]
  106. Ataabadi S.M. Alaee S. Bagheri M.J. Bahmanpoor S. Role of essential oil of Mentha spicata (Spearmint) in addressing reverse hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome in a rat model. Adv. Pharm. Bull. 2017 7 4 651 654 10.15171/apb.2017.078 29399556
    [Google Scholar]
  107. Iervolino M. Lepore E. Forte G. Laganà A.S. Buzzaccarini G. Unfer V. Natural molecules in the management of polycystic ovary syndrome (PCOS): An analytical review. Nutrients 2021 13 5 1677 10.3390/nu13051677 34063339
    [Google Scholar]
  108. Tamilselvi S Nalini SJ Int. J. Res. Pharm. Sci.
    [Google Scholar]
  109. Satapathy S. Das N. Bandyopadhyay D. Mahapatra S.C. Sahu D.S. Meda M. Effect of Tulsi (Ocimum sanctum Linn.) supplementation on metabolic parameters and liver enzymes in young overweight and obese subjects. Indian J. Clin. Biochem. 2017 32 3 357 363 10.1007/s12291‑016‑0615‑4 28811698
    [Google Scholar]
  110. Cohen M. Tulsi - Ocimum sanctum: A herb for all reasons. J. Ayurveda Integr. Med. 2014 5 4 251 259 10.4103/0975‑9476.146554 25624701
    [Google Scholar]
  111. Prakash P. Gupta N. Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions: A short review. Indian J. Physiol. Pharmacol. 2005 49 2 125 131 16170979
    [Google Scholar]
  112. Pachiappan S. Matheswaran S. Saravanan P.P. Muthusamy G. Medicinal plants for polycystic ovary syndrome: A review of phytomedicine research. Int. J. Herb. Med. 2017 5 2 78 80
    [Google Scholar]
  113. Husein H.I. Tukan S. Alkazaleh F. The effect of marjoram (O riganum majorana ) tea on the hormonal profile of women with polycystic ovary syndrome: A randomised controlled pilot study. J. Hum. Nutr. Diet. 2016 29 1 105 111 10.1111/jhn.12290 25662759
    [Google Scholar]
  114. Wang J.G. Anderson R.A. Graham G.M. III Chu M.C. Sauer M.V. Guarnaccia M.M. Lobo R.A. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: A pilot study. Fertil. Steril. 2007 88 1 240 243 10.1016/j.fertnstert.2006.11.082 17296187
    [Google Scholar]
  115. Zambare K.K. Thalkari A.B. Tour N.S. Reddy K.V. Herbal remedies for treatment of polycystic ovary syndrome. Asian J. Pharm. Technol. 2019 9 2 112 114 10.5958/2231‑5713.2019.00019.9
    [Google Scholar]
  116. Poornima R. Saranya P. Bhuvaneshwari S. Averal H.I. Evaluation of Pergularia daemia and metformin in the treatment of PCOS in testosterone propionate induced albino wistar rats (Rattus norvegicus). Int J Sci Res Pub. 2015 5 503 509
    [Google Scholar]
  117. Olabisi F.FJ Komolafe MO Oladoye O Alabi TS Safety evaluation of ethanolic extract of Parquetina nigrescens leaves (Afzel.) on selected tissues in letrozole-induced polycystic ovarian syndrome rats. MUJAST 2022 2 2 7 14
    [Google Scholar]
  118. Shehzad M. Rasheed H. Naqvi S.A. Khayri A.J.M. Lorenzo J.M. Alaghbari M.A. Manzoor M.F. Aadil R.M. Therapeutic potential of date palm against human infertility: A review. Metabolites 2021 11 6 408 10.3390/metabo11060408 34205817
    [Google Scholar]
  119. Jashni K.H. Jahromi K.H. Bagheri Z. The effect of palm pollen extract on polycystic ovary syndrome (POS) in rats. Int. J. Med. Res. Health Sci. 2016 5 5 317 321
    [Google Scholar]
  120. Hossein K. Leila K. Ebrahim T. Nazanin S. Farzad P. Elham R. Mohammad P. Zahra H. The effect of pomegranate juice extract on hormonal changes of female Wistar rats caused by polycystic ovarian syndrome. Biomed. Pharmacol. J. 2015 8 2 971 977 10.13005/bpj/849
    [Google Scholar]
  121. Ashkar F. Eftekhari H.M. Tanideh N. Koohpeyma F. Mokhtari M. Irajie C. Iraji A. Effect of hydroalcoholic extract of Berberis integerrima and resveratrol on ovarian morphology and biochemical parameters in Letrozole-induced polycystic ovary syndrome rat model: An experimental study. Int. J. Reprod. Biomed. 2020 18 8 637 650 10.18502/ijrm.v13i8.7505 32923930
    [Google Scholar]
  122. Hayek E.S. Bitar L. Hamdar L.H. Mirza F.G. Daoud G. Polycystic ovarian syndrome: An updated overview. Front. Physiol. 2016 7 1 124 128 10.3389/fphys.2016.00124 27092084
    [Google Scholar]
  123. Noroozzadeh M. Gandevani B.S. Vakili Z.A. Tehrani R.F. Hormone-induced rat model of polycystic ovary syndrome: A systematic review. Life Sci. 2017 191 259 272 10.1016/j.lfs.2017.10.020 29055801
    [Google Scholar]
  124. Bajpai N. Roy A. Sen B. Polycystic ovarian syndrome and endometrial receptivity current perspectives and solution through Ayurveda: A review. Int. J. Res. Ayush Allied Syst. 2023 10 4 26 35 10.47070/ayushdhara.v10i4.1299
    [Google Scholar]
  125. Chandrasekaran C. Herbal approach for obesity management. Amer. J. Plant Sci. 2012 3 1003 1014
    [Google Scholar]
  126. Devi M.S. Muralidharan P.M. Hari R. Lavanya M. Abiraamavalli T.A. PCOS modulatory activity of tinospora cordifolia leaves–An in silico approach. Biomed. Pharmacol. J. 2021 14 3 1125 1131 10.13005/bpj/2215
    [Google Scholar]
  127. Sultana S. Akhter N. Akram M. Shah S.M. Munir N. Riaz M. Prevalence, symptomatology and herbal management of polycystic ovarian syndrome. Alternative Medicine-Update IntechOpen 2020
    [Google Scholar]
  128. Lakshmi J.N. Babu A.N. Kiran S.S.M. Nori L.P. Hassan N. Ashames A. Bhandare R.R. Shaik A.B. Herbs as a source for the treatment of polycystic ovarian syndrome: A systematic review. BioTech 2023 12 1 4 10.3390/biotech12010004 36648830
    [Google Scholar]
  129. Bashtian H.M. Emami S.A. Mousavifar N. Esmaily H.A. Mahmoudi M. Poor M.A.H. Evaluation of fenugreek (Trigonella foenum-graceum L.), effects seeds extract on insulin resistance in women with polycystic ovarian syndrome. Iran. J. Pharm. Res. 2013 12 2 475 481 24250624
    [Google Scholar]
  130. Feyzollahi Z. Kouchesfehani M.H. Jalali H. Esfahani E.D. Hosseini S.A. Effect of Vitex agnus-castus ethanolic extract on hypothalamic KISS-1 gene expression in a rat model of polycystic ovary syndrome. Avicenna J. Phytomed. 2021 11 3 292 301 34046325
    [Google Scholar]
  131. Poojari P. Paramanya A. Singh D. Ali A. Polycystic ovarian syndrome: Causes and therapies by herbal medicine. In Herbal Medicines Academic Press 2022 435 451 10.1016/B978‑0‑323‑90572‑5.00028‑7
    [Google Scholar]
  132. Shrivastava R. Mishra S. Singh R. Shrivastava P. Effect of integrated approach of yoga and naturopathy on polycystic ovarian syndrome: A case study. J. Family Med. Prim. Care 2022 11 4 1525 1527 10.4103/jfmpc.jfmpc_651_21 35516692
    [Google Scholar]
  133. Akhtar P. Yardi S. Akhtar M. Effects of yoga on functional capacity and well being. Int. J. Yoga 2013 6 1 76 79 10.4103/0973‑6131.105952 23439856
    [Google Scholar]
  134. Arentz S. Smith C.A. Abbott J. Fahey P. Cheema B.S. Bensoussan A. Combined lifestyle and herbal medicine in overweight women with polycystic ovary syndrome (PCOS): A randomized controlled trial. Phytother. Res. 2017 31 9 1330 1340 10.1002/ptr.5858 28685911
    [Google Scholar]
  135. Wu H. Zhao B. Yao Q. Kang J. Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes. J. Ovarian Res. 2023 16 1 207 10.1186/s13048‑023‑01299‑8 37880784
    [Google Scholar]
/content/journals/nemj/10.2174/0102506882339236250105165820
Loading
Exploring the Intricacies of Polycystic Ovarian Syndrome (PCOS): A Comprehensive Review-from Prevalence to Natural Solutions
Bentham Science Publishers , e02506882339236; https://doi.org/10.2174/0102506882339236250105165820
/content/journals/nemj/10.2174/0102506882339236250105165820
/content/journals/nemj/10.2174/0102506882339236250105165820
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Polycystic ovarian syndrome (PCOS) ; Infertility ; Herbal plants ; Hormonal imbalance ; Puberty

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test